Neuroblastoma: Epidemiology and Pattern of Regression Problems in Interpreting Results of Mass Screening

No abstract is available for this paper.

• Publication year

  1992

• Venue

  American Journal Of Pediatric Hematology/Oncology

• Publication date

  1992-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00043426-199205000-00003PMID 1530115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromosome abnormalities, cellular DNA content, oncogene amplification and growth pattern in agar culture of human neuroblastomas.

  1991cited by this paper
• Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.

  1991cited by this paper
• A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group.

  1990cited by this paper
• Where next with therapy in advanced neuroblastoma?

  1990cited by this paper
• How frequent is spontaneous remission of neuroblastomas? Implications for screening.

  1990cited by this paper
• Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.

  1990cited by this paper
• Problems of mass screening for neuroblastoma: analysis of false-negative cases.

  1990cited by this paper
• Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.

  1990cited by this paper
• Decrease in childhood neuroblastoma death in Japan.

  1990cited by this paper
• Cases of Neuroblastoma Missed by the Mass Screening Programs

  1989cited by this paper
• The ninth Gordon Hamilton-Fairley memorial lecture. Hereditary cancers: clues to mechanisms of carcinogenesis.

  1989cited by this paper
• A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVA.

  1989cited by this paper
• Incidence of childhood cancer in Denmark 1943-1984.

  1989cited by this paper
• Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1

  1989cited by this paper
• Laboratory techniques and neuroblastoma screening.

  1988cited by this paper
• Trends in the incidence of childhood and adolescent cancer in Connecticut, 1935-1979.

  1988cited by this paper
• Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study.

  1988cited by this paper
• Why age has independent prognostic significance in neuroblastomas. Evidence for intra-uterine development, and implications for the treatment of the disease.

  1988cited by this paper
• Flow cytometric DNA analysis of Neuroblastoma and Ganglioneuroma. A 10‐year retrospective study

  1988cited by this paper
• Chromosomes in solid tumors and beyond.

  1988cited by this paper
• Tumorigenicity and oncogene expression in pediatric cancers.

  1988cited by this paper
• Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.

  1987cited by this paper
• Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression.

  1987cited by this paper
• Effects of the mass screening of neuroblastoma in sapporo city

  1987cited by this paper
• Neuroblastoma: the case for screening infants in North America.

  1987cited by this paper
• Signs, symptoms, metastatic spread and metabolic behavior of neuroblastomas treated in Denmark during the period 1943-1980.

  1987cited by this paper
• Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects.

  1987cited by this paper
• Progress against cancer?

  1986cited by this paper
• Conditioned tumorigenicity of activated oncogenes.

  1986cited by this paper
• Epidemiological investigations on neuroblastomas in Denmark 1943-1980.

  1986cited by this paper
• Prognostic factors in neuroblastomas treated in denmark from 1943 to 1980: A statistical estimate of prognosis based on 253 cases

  1986cited by this paper
• Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome.

  1986cited by this paper
• Clinical implications of tumor-cell heterogeneity.

  1986cited by this paper
• Hereditary cancer, oncogenes, and antioncogenes.

  1985cited by this paper
• The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

  1985cited by this paper
• Neuroblastoma. Mass screening for early detection and its prognosis

  1984cited by this paper
• Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal.

  1981cited by this paper
• Mutation and cancer: a model for human carcinogenesis.

  1981cited by this paper
• Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.

  1980cited by this paper
• CHILDHOOD CANCER IN SWEDEN, 1958–1974

  1978cited by this paper
• Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.

  1978cited by this paper
• Incidence of childhood cancer in Finland.

  1975cited by this paper
• Role of embryonic induction in benign transformation of neuroblastomas

  1967cited by this paper
• IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS.

  1963cited by this paper
• NEUROCYTOMA OR NEUROBLASTOMA, A KIND OF TUMOR NOT GENERALLY RECOGNIZED

  1910cited by this paper

• Neuroblastoma in a 17‐week fetus: A stimulus for investigation of tumors in a series of 2786 stillbirth and late miscarriages

  2015cites this paper
• Blueberry-Muffin Lesions in a Baby

  2013cites this paper
• Estudio de expresión de marcadores de células madre neurales en neuroblastoma y correlación con factores pronóstico

  2013cites this paper
• Nervous system: Peripheral neuroblastic tumours (Neuroblastoma, Ganglioneuroblastoma, Ganglioneuroma)

  2011cites this paper
• Examining different levels of prevention of birth defects and fetal alcohol spectrum disorder.

  2009cites this paper
• The Adrenal Gland

  2008cites this paper
• Nordihydroguaiaretic acid inhibits insulin‐like growth factor signaling, growth, and survival in human neuroblastoma cells

  2007cites this paper
• Adrenal surgery in the pediatric population

  2007cites this paper
• Growth Factor 11 in the Pathogenesis of Human Neuroblastoma

  2007cites this paper
• Incidence of neuroblastoma after a screening program.

  2007cites this paper
• Direct evidence on the immune-mediated spontaneous regression of human cancer: an incentive for pharmaceutical companies to develop a novel anti-cancer vaccine.

  2005cites this paper
• Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells

  2005cites this paper
• EDITORIALS Ras and Seppuku in Neuroblastoma

  2002cites this paper
• Ras and Seppuku in neuroblastoma.

  2002cites this paper
• Neuroblastome

  2001cites this paper
• J Moppett, I Haddadin, ABMF oot, on behalf of the United Kingdom Children's Cancer Study Group

  1999cites this paper
• Review Screening for Neuroblastoma: Progress and Pitfalls 1

  1999cites this paper
• Prenatal diagnosis of fetal adrenal masses: differentiation between hemorrhage and solid tumor by color Doppler sonography

  1999cites this paper
• Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States.

  1999cites this paper
• Screening for neuroblastoma: progress and pitfalls.

  1999cites this paper
• Neonatal neuroblastoma

  1999cites this paper
• IVSYMPATHETIC NERVOUS SYSTEM TUMORS 65 National Cancer Institute SEER Pediatric Monograph

  1999cites this paper
• Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the Evaluation of Neuroblastoma Screening in Europe.

  1998cites this paper
• Compliance in a screening program for neuroblastoma.

  1998cites this paper
• Dépistage

  1998cites this paper
• Pathology review of screening negative neuroblastomas

  1998cites this paper
• Screening for neuroblastoma in children: elements for a statistical evaluation

  1998cites this paper
• What can we expect from neuroblastoma screening? Clinicians point of view

  1998cites this paper
• Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method: 115000 screened infants in Austria.

  1997cites this paper
• Fetal adrenal hemorrhage in a diamniotic, dichorionic twin: case report and review of controversies in diagnosis and management

  1997cites this paper
• Neuroblastoma and insulin-like growth factor system. New insights and clinical perspectives.

  1997cites this paper
• Diagnostic imaging in abdominal neuroblastoma: Is there a complementary role of MIBG-scintigraphy and ultrasonography?

  1997cites this paper
• Infant Cancer in the U.S.: Histology‐Specific Incidence and Trends, 1973 to 1992

  1997cites this paper
• Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.

  1997cites this paper
• Neuroblastomas presenting in the first year of life: epidemiological differences from those presenting at older ages.

  1996cites this paper
• Connatal localized neuroblastoma: The case to delay treatment

  1996cites this paper
• Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method : 115 000 screened infants in Austria

  1996cites this paper
• Spontaneous regression of cancer.

  1996influential citation
• Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis.

  1996cites this paper
• Nursing management of the infant with a congenital malignancy.

  1996cites this paper
• In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: relation to apoptosis and spontaneous regression.

  1996cites this paper
• Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.

  1996cites this paper
• Age‐related profile of neuroblastoma: A comparison of tumors detected by mass‐screening with those detected clinically

  1995cites this paper
• Ultrasound in Screening for Neonatal Adrenal Hemorrhage

  1995cites this paper
• Animal Models of Medulloblastomas and Related Primitive Neuroectodermal Tumors. A Review

  1995cites this paper
• The impact of 123I-meta-iodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma.

  1995cites this paper
• The changing face of paediatric oncology

  1995cites this paper
• Insulin-like growth factor II in the pathogenesis of human neuroblastoma.

  1995cites this paper
• trk A Gene expression in neuroblastoma. The clinical significance of an immunohistochemical study

  1995cites this paper
• Dynamics of cell proliferation and cell death during the emergence of primitive neuroectodermal tumors of the immature central nervous system in transgenic mice.

  1995cites this paper
• Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells.

  1995cites this paper
• Is neuroblastoma screening evaluation needed and feasible?

  1995cites this paper
• Neuroblastomas in Denmark 1943‐80. Epidemiological and Clinical Studies

  1994cites this paper
• Sudden infant death syndrome.

  1994cites this paper
• Immunomodulatory effects of human neuroblastoma cells transduced with a retroviral vector encoding interleukin-2.

  1994cites this paper
• The physician's hands and early detection of neuroblastoma.

  1994cites this paper
• Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history.

  1994cites this paper
• Paediatric Reference Ranges for Urinary Catecholamines/Metabolites and Their Relevance in Neuroblastoma Diagnosis

  1994cites this paper
• Massive hepatomegaly in a 6-week-old infant: is it neuroblastoma?

  1994cites this paper
• Induction of Interleukin-8 Expression in Neuroblastoma Cells by Retinoic Acid: Implication of Leukocyte Chemotaxis and Activation

  1993cites this paper
• LETTERS TO THE EDITOR Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history in case conferences

  year unknowncites this paper
• Testing of Scoring Systems for Predicting Infants with High-risk of Sudden Infant Death Syndrome

  year unknowncites this paper